Dominik Ellenrieder

Dominik has been a part of the Endeavour Vision team since 2007. He is a serial entrepreneur with over 27 years of experience in building and managing successful medical technology companies. He’s served as both an executive and board member in both Europe and in the USA.

Before moving to Endeavour Vision, Dominik held executive positions across a number of departments and as deputy CEO at STRATEC Medical – a world leading company in orthopaedics and trauma. He was one of the core team who participated in the MBO in 1990, in the IPO on the SWX in 1996, and in the 1999 strategic sale to Synthes. He held executive positions in marketing and product management at Straumann in the late 80s, a company which is a world leader in fracture treatment, dental implants and metallurgy. Before that, Dominik held several positions in sales and finally served as Head of International Sales at Protek AG, a joint replacement company (Sulzer Medica, Zimmer).

Dominik was on the board of directors of Straumman until early 2014, was Chairman of Symetis until its exit in 2017, and is currently a Board member or Chairman of the Board for Sentec, Qgel and Medartis.

Dominik graduated in Economics from the University of Basel and then completed an MBA at GSBA in Boston, USA.